Glen Clack has joined Evgen Pharma Plc, a UK drug development company, as chief medical officer. Dr Clack has over 30 years of experience in oncology and translational medicine, including nearly 20 years at AstraZeneca Plc. He specialises in early phase oncology clinical development. Dr Clack holds honorary academic positions at the Universities of Sheffield and Manchester in the UK, and has published over 50 academic papers on various cancers. He has a bachelor of medicine degree from the Royal Free Hospital School of Medicine and an MD from the University of Sheffield, both in the UK.
Evgen announced the appointment on 26 April 2021.
Copyright 2021 Evernow Publishing Ltd